Back

Introduction and learning objectives.

31 August 2020 (18:30 - 18:32)
Organised by:
Congress Presentation Part of: Medtronic Leading with Evidence: Latest data from Evolut TAVI and Renal Denervation Treatment Open Access ESC Congress 2020

About the speaker

Photo
Doctor Jeffrey Popma

Beth Israel Deaconess Medical Center, Boston (United States of America)

5 More presentations in this session

Presentation thumbnail
Paradigm shifting evidence in TAVI – Evolut low risk trial and sub analyses.
Doctor J. Popma (Boston, US)
Video
Presentation thumbnail
The importance of valve hemodynamics – Why should it be a priority in TAVI?
Professor M. Abdel-Wahab (Leipzig, DE)
Video
Presentation thumbnail
A Pivotal moment for renal denervation.
Professor M. Boehm (Homburg, DE)
Video
Presentation thumbnail
Addressing the Population Question: Who is the Renal Denervation Patient?
Professor A. Pathak (Luxembourg, LU)
Video
Presentation thumbnail
Session conclusion and take home messages.
Doctor J. Popma (Boston, US)

Access the full session

Session thumbnail
Medtronic Leading with Evidence: Latest data from Evolut TAVI and Renal Denervation
Video

The Event

Event poster

ESC Congress 2020

31 August 2020 18:30 CET
You may be interested in
thumbnail
Congress Session
Optimal implantation technique for PM and ICD
16 April 2023
thumbnail
Webinar
Structural heart interventions in aortic valvular disease - IC Core Curriculum 2
4 May 2022
thumbnail
Congress Session
Alert-based remote monitoring: changing the paradigm of CIED follow-up
30 March 2025
thumbnail
Congress Session
Late-Breaking Science: devices
9 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources